It secured total revenue of $11.49bn in the quarter.
General meeting secures go-ahead after six months of uncertainty caused by Jonathan Milner bid.
The all-in-one automated solution accelerates research.
Cyto-Mine company’s new labs opened by Deputy Lieutenant of Cambridgeshire.
Anthony Finbow becomes chief evangelist in senior management all-change.
Final pitches ahead of November 6 vote as market compares offers.
LiveL@bs operations manager Ruth Campbell welcomes users to new facility.
New LiveL@bs facility opens up site to all pharma start-ups
Event showcases open science approach for global pharma.
‘It’s important for shareholders to exercise their views,’ says Alan Hirzel of November 6 general meeting.
Babraham Research Campus company focuses on therapeutic antibodies for companion animals.
Cambridge company developing ‘new class of therapies designed in data-driven way’.
Moulton-based charity helping drive forward treatments for dementia.
It tops the 2023 Global Innovation Index.
New Cambridge company founded by Mark Kotter, bit.bio founder and CEO.